- Home
- PLUR vs MDCX Comparison
PLUR vs MDCX Comparison
Compare PLUR & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLUR | MDCX |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 10.9M |
| IPO Year | 2026 | 2025 |
Fundamental Metrics
Financial Performance| Metric | PLUR | MDCX |
|---|---|---|
| Price | $0.95 | $3.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $225.00 |
| AVG Volume (30 Days) | 13.6K | ★ 2.5M |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,016,000.00 | N/A |
| Revenue This Year | $902.46 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.85 | $0.08 |
| 52 Week High | $4.87 | $4.69 |
Technical Indicators
Market Signals| Indicator | PLUR | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 32.70 | 87.94 |
| Support Level | $0.90 | $0.27 |
| Resistance Level | $1.85 | N/A |
| Average True Range (ATR) | 0.09 | 0.15 |
| MACD | 0.01 | 0.38 |
| Stochastic Oscillator | 27.43 | 68.52 |
Price Performance
Historical ComparisonAbout PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.